These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

852 related items for PubMed ID: 28566298

  • 1. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW, Tian L, Wu D, Thenappan T, Metzger JM, Archer SL.
    J Am Heart Assoc; 2017 May 31; 6(6):. PubMed ID: 28566298
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.
    Prisco SZ, Hartweck LM, Rose L, Lima PDA, Thenappan T, Archer SL, Prins KW.
    Circ Heart Fail; 2022 Jan 31; 15(1):e008574. PubMed ID: 34923829
    [Abstract] [Full Text] [Related]

  • 3. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
    Xie YP, Chen B, Sanders P, Guo A, Li Y, Zimmerman K, Wang LC, Weiss RM, Grumbach IM, Anderson ME, Song LS.
    Hypertension; 2012 Feb 31; 59(2):355-62. PubMed ID: 22203744
    [Abstract] [Full Text] [Related]

  • 4. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M, Sala L, Rizzetto R, Staszewsky LI, Alemanni M, Zambelli V, Russo I, Barile L, Cornaghi L, Altomare C, Ronchi C, Mostacciuolo G, Lucchetti J, Gobbi M, Latini R, Zaza A.
    Cardiovasc Res; 2014 Oct 01; 104(1):37-48. PubMed ID: 25139747
    [Abstract] [Full Text] [Related]

  • 5. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Lambert M, Boet A, Rucker-Martin C, Mendes-Ferreira P, Capuano V, Hatem S, Adão R, Brás-Silva C, Hautefort A, Michel JB, Dorfmuller P, Fadel E, Kotsimbos T, Price L, Jourdon P, Montani D, Humbert M, Perros F, Antigny F.
    Cardiovasc Res; 2018 May 01; 114(6):880-893. PubMed ID: 29360952
    [Abstract] [Full Text] [Related]

  • 6. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R, Mendes-Ferreira P, Santos-Ribeiro D, Maia-Rocha C, Pimentel LD, Monteiro-Pinto C, Mulvaney EP, Reid HM, Kinsella BT, Potus F, Breuils-Bonnet S, Rademaker MT, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C.
    Cardiovasc Res; 2018 Jul 01; 114(8):1165-1177. PubMed ID: 29584808
    [Abstract] [Full Text] [Related]

  • 7. 17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.
    Wang YD, Li YD, Ding XY, Wu XP, Li C, Guo DC, Shi YP, Lu XZ.
    Int J Cardiovasc Imaging; 2019 Mar 01; 35(3):441-450. PubMed ID: 30350115
    [Abstract] [Full Text] [Related]

  • 8. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A.
    Am J Physiol Heart Circ Physiol; 2009 Nov 01; 297(5):H1606-16. PubMed ID: 19783775
    [Abstract] [Full Text] [Related]

  • 9. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A, Trappiel M, Berghausen EM, Ten Freyhaus H, Wellnhofer E, Odenthal M, Blaschke F, Er F, Gassanov N, Rosenkranz S, Baldus S, Kappert K, Caglayan E.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr 01; 389(4):369-79. PubMed ID: 26742933
    [Abstract] [Full Text] [Related]

  • 10. Distinct right ventricle remodeling in response to pressure overload in the rat.
    Mendes-Ferreira P, Santos-Ribeiro D, Adão R, Maia-Rocha C, Mendes-Ferreira M, Sousa-Mendes C, Leite-Moreira AF, Brás-Silva C.
    Am J Physiol Heart Circ Physiol; 2016 Jul 01; 311(1):H85-95. PubMed ID: 27199115
    [Abstract] [Full Text] [Related]

  • 11. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM, Mik EG, Eerbeek O, Specht PA, van der Laarse WJ, Zuurbier CJ.
    Respir Res; 2015 Feb 03; 16(1):6. PubMed ID: 25645252
    [Abstract] [Full Text] [Related]

  • 12. Ursolic Acid Improves Monocrotaline-Induced Right Ventricular Remodeling by Regulating Metabolism.
    Gao X, Zhang Z, Li X, Wei Q, Li H, Li C, Chen H, Liu C, He K.
    J Cardiovasc Pharmacol; 2020 Jun 03; 75(6):545-555. PubMed ID: 32141989
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin Receptor-Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension.
    Sharifi Kia D, Benza E, Bachman TN, Tushak C, Kim K, Simon MA.
    J Am Heart Assoc; 2020 Jul 07; 9(13):e015708. PubMed ID: 32552157
    [Abstract] [Full Text] [Related]

  • 14. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats.
    Campos-Carraro C, Turck P, de Lima-Seolin BG, Tavares AMV, Dos Santos Lacerda D, Corssac GB, Teixeira RB, Hickmann A, Llesuy S, da Rosa Araujo AS, Belló-Klein A.
    J Cardiovasc Pharmacol; 2018 Nov 07; 72(5):214-221. PubMed ID: 30212415
    [Abstract] [Full Text] [Related]

  • 15. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM, Chaudhary KR, Deng Y, Jiang B, Stewart DJ.
    Cardiovasc Res; 2019 Mar 15; 115(4):788-799. PubMed ID: 30357319
    [Abstract] [Full Text] [Related]

  • 16. Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
    Prisco SZ, Rose L, Potus F, Tian L, Wu D, Hartweck L, Al-Qazazi R, Neuber-Hess M, Eklund M, Hsu S, Thenappan T, Archer SL, Prins KW.
    Int J Mol Sci; 2020 Oct 01; 21(19):. PubMed ID: 33019763
    [Abstract] [Full Text] [Related]

  • 17. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS.
    Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924
    [Abstract] [Full Text] [Related]

  • 18. Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.
    Conzatti A, Colombo R, Siqueira R, Campos-Carraro C, Turck P, Luz de Castro A, Belló-Klein A, Sander da Rosa Araujo A.
    J Cardiovasc Pharmacol; 2024 Jun 01; 83(6):612-620. PubMed ID: 38547510
    [Abstract] [Full Text] [Related]

  • 19. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Nguyen QT, Nsaibia MJ, Sirois MG, Calderone A, Tardif JC, Fen Shi Y, Ruiz M, Daneault C, Gagnon L, Grouix B, Laurin P, Dupuis J.
    Cardiovasc Res; 2020 Jan 01; 116(1):171-182. PubMed ID: 30753422
    [Abstract] [Full Text] [Related]

  • 20. Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension.
    Kwan ED, Hardie BA, Garcia KM, Mu H, Wang TM, Valdez-Jasso D.
    Am J Physiol Heart Circ Physiol; 2024 Aug 01; 327(2):H351-H363. PubMed ID: 38847755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.